Active topical NS2 1% dermatologic cream
NS-003
Phase 2 small_molecule completed
Quick answer
Active topical NS2 1% dermatologic cream for Sjögren-Larsson Syndrome is a Phase 2 program (small_molecule) at Aldeyra Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Aldeyra Therapeutics
- Indication
- Sjögren-Larsson Syndrome
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed